Seven-senescence-associated gene signature predicts overall survival for Asian patients with hepatocellular carcinoma

doi:10.3748/wjg.v25.i14.1715

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 25, Issue 14

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (10322)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-6) series, Tables (1-2) series.

Item

Count

PDF

625

WORD

319

HTML

6629

Figures (1-6)

315

Tables (1-2)

316

Sum=8204

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

731

Download

1387

Sum=2118

Apr 14, 2019 (publication date) through Feb 5, 2025

Times Cited of This Article

Times Cited (31)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Gastroenterol. Apr 14, 2019; 25(14): 1715-1728
Published online Apr 14, 2019. doi: 10.3748/wjg.v25.i14.1715

Table 1 Univariate/multivariate Cox regression analysis of clinicopathologic factors associated with overall survival in GSE14520 and The Cancer Genome Atlas cohorts

Variable	Discovery cohort				Validation cohort-Asian only
	Univariate analysis		Multivariate analysis		Univariate analysis		Multivariate analysis
	HR (95%CI)	P-value	HR (95%CI)	P-value	HR (95%CI)	P-value	HR (95%CI)	P-value
Gender (male/female)	1.36 (0.55-3.40)	0.507	-	-	0.89 (0.43-1.86)	0.755	-	-
Age (> 60/≤ 60 yr)	1.06 (0.57-2.00)	0.851	-	-	1.21 (0.66-2.24)	0.541	-	-
Cirrhosis (yes/no)	3.09 (0.76-12.65)	0.117	-	-	2.44 (1.56-3.85)	< 0.001^a	1.67 (1.04-2.70)	0.034^a
AFP (> 300/≤ 300 ng/mL)	2.30 (1.37-3.86)	0.002^a	2.26 (1.38-3.69)	0.001^a	3.70 (2.13-6.25)	< 0.001^a	2.13 (1.30-3.57)	0.003^a
Risk score (high/low)	1.93 (1.15-3.23)	0.012^a	1.99 (1.19-3.34)	0.009^a	5.91 (2.74-12.76)	< 0.001^a	4.22 (1.89-9.41)	< 0.001^a

^aStatistically significant. HR: Hazard ratio; CI: Confidence interval; AFP: Alpha-fetoprotein.

Table 2 Stratified analysis of overall survival in GSE14520 and The Cancer Genome Atlas cohorts

Variable	Discovery cohort			Validation cohort-Asian only
Variable	High-risk/low-risk	HR (95%CI)	P-value	High-risk/low-risk	HR (95%CI)	P-value
Overall	76/75	1.92 (1.16-3.19)	0.011^a	79/78	5.81 (3.20-10.54)	< 0.001^a
Gender
Male	69/67	2.15 (1.27-3.64)	0.004^a	62/61	5.18 (2.66-10.10)	< 0.001^a
Female	7/8	0.60 (0.10-3.47)	0.569	17/17	9.63 (2.59-35.77)	0.009^a
Age (yr)
≤ 60	64/60	1.70 (0.97-2.98)	0.064	53/52	5.22 (2.49-10.97)	< 0.001^a
> 60	12/15	3.19 (1.00-10.20)	0.045^a	26/26	6.47 (2.38-17.59)	< 0.001^a
Cirrhosis
Yes	70/69	1.93 (1.15-3.22)	0.012^a	17/24	3.50 (0.66-18.47)	0.122
No	6/6	1.73 (0.10-30.65)	0.695	11/28	0.98 (0.19-5.00)	0.979
AFP (ng/mL)
≤ 300	40/39	1.73 (0.77-3.87)	0.179	34/55	2.94 (1.01-8.57)	0.036^a
> 300	34/34	2.11 (1.09-4.08)	0.025^a	16/16	2.65 (0.60-11.66)	0.226

^aStatistically significant. HR: Hazard ratio; CI: Confidence interval; AFP: Alpha-fetoprotein.

Citation: Xiang XH, Yang L, Zhang X, Ma XH, Miao RC, Gu JX, Fu YN, Yao Q, Zhang JY, Liu C, Lin T, Qu K. Seven-senescence-associated gene signature predicts overall survival for Asian patients with hepatocellular carcinoma. World J Gastroenterol 2019; 25(14): 1715-1728
URL: https://www.wjgnet.com/1007-9327/full/v25/i14/1715.htm
DOI: https://dx.doi.org/10.3748/wjg.v25.i14.1715